Quality of life in patients with locally advanced metastatic breast cancer after palliative treatment
DOI:
https://doi.org/10.12775/JEHS.2025.77.60768Keywords
metastatic breast cancer, surgical treatment, palliative treatment, quality of life, questionnaire, mental condition, physical condition, social conditionAbstract
The majority of scientists obtain subjective data by patients surveying using questionnaire. More than 400 different general and special questionnaires have been proposed and used to assess the quality of life in modern oncology. The purpose of the study was to evaluate the quality of life in the fields of mental and physical conditions of patients with metastatic breast cancer who underwent palliative surgery compared with patients who received standard treatment regimens, and to determine the level of satisfaction with social relationships. Due to quality of life concept multifactorial nature the questionnaire takes into account three main aspects: physical (medical), psychological and social. The data obtained allow to state that breast cancer patients quality of life self-perception depends on the methods of treatment used: intra-arterial polychemotherapy, radiotherapy, hormone therapy, bisphosphonate therapy and palliative surgery. In the areas of mental and physical condition, the quality of life was higher in patients in the experimental group than in patients in the control group, where they received standard treatment without surgery.
References
1. Dumanskiy YuV, Bondar OV, Tkachenko OI, Stolyarchuk EA. Comparative characteristics of the quality of life of patients with locally advanced breast cancer after regional and intravenous chemotherapy. Clin Surgery. 2018; 85(6): 55-59. [In Ukrainian]
2. Dumanskiy YuV, Bondar OV, Tkachenko OI, Stolyarchuk EA. Comparative characteristics of the quality of life of patients with locally advanced forms of breast cancer after polychemotherapy in systemic and intralymphatic regimens. Clin Surgery. 2018; 85(9): 61-65. [In Ukrainian]
3. Kuznetsova OV, Stepula VV, Nikel B, Shandra OA, Vastyanov RS. Comparative neurotoxicity studies under the conditions of use of different antitumor drugs. Odessa Medical Journal. 2005; 3: 21-25. [In Ukrainian]
4. Ashinuma H, Sekine I. Targeted therapy for solid tumors in the elderly. Nihon Rinsho. 2015; 73(8): 1419-1424.
5. Bondar OV. The quality of life role in patients with locally advanced breast cancer in the comprehensive evaluation of the complex neoadjuvant treatment efficiency. Journal of Education, Health and Sport. 2019; 9(11): 371-380.
6. Botteri E, Veronesi P, Vila J, Rotmensz N, Galimberti V, Thomazini MV. Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery time. Br J Surg. 2017; 104(13): 1802-1810. doi: 10.1002/bjs.10658.
7. Dumanskiy Y, Bondar O, Тkachenko O, Stoliarchuk E, Ermakov V. Comparison of quality of life of patients with local distributed breast cancer forms after chemotherapy in regional and system regimes. EUREKA: Health Sciences. 2018; (3): 12-20.
8. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P. et al. Breast cancer. Nat Rev Dis Primers. 2019; 5(1): 66. doi: 10.1038/s41572-019-0111-2
9. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Fort Washington PA: NCCN; 2015. Ver. 2.2015.
10. Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM. et al. Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clin Breast Cancer. 2019; 19(4):292-303. doi: 10.1016/j.clbc.2019.02.003.
11. Moroz VM, Shandra OA, Vastyanov RS, Yoltukhivsky MV, Omelchenko OD. Physiology. Vinnytsia: Nova Knyha. 2016. 722.
12. Simos D, Clemons M, Ginsburg OM, Jacobs C. Definition and consequences of locally advanced breast cancer. Curr Opin Support Palliat Care. 2014; 8: 33–38. doi: 10.1097 SPC.0000000000000020.
13. Zhang W, Liu R, Wang Y, Qian S, Wang J, Yan Z, Zhang H. Efficacy of intraarterial chemoinfusion therapy for locally advanced breast cancer patients: a retrospective analysis of 28 cases. Onco Targets Ther. 2015; 6: 761-765. doi: 10.2147/OTT.S44882.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 O. Bondar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 120
Number of citations: 0